Rodríguez-Pombo Lucía, Awad Atheer, Basit Abdul W, Alvarez-Lorenzo Carmen, Goyanes Alvaro
Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Materials Institute iMATUS and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.
Pharmaceutics. 2022 Aug 18;14(8):1732. doi: 10.3390/pharmaceutics14081732.
Since their introduction, chewable dosage forms have gained traction due to their ability to facilitate swallowing, especially in paediatric, geriatric and dysphagia patients. Their benefits stretch beyond human use to also include veterinary applications, improving administration and palatability in different animal species. Despite their advantages, current chewable formulations do not account for individualised dosing and palatability preferences. In light of this, three-dimensional (3D) printing, and in particular the semi-solid extrusion technology, has been suggested as a novel manufacturing method for producing customised chewable dosage forms. This advanced approach offers flexibility for selecting patient-specific doses, excipients, and organoleptic properties, which are critical for ensuring efficacy, safety and adherence to the treatment. This review provides an overview of the latest advancements in chewable dosage forms for human and veterinary use, highlighting the motivations behind their use and covering formulation considerations, as well as regulatory aspects.
自引入以来,咀嚼剂型因其有助于吞咽的能力而受到欢迎,尤其是在儿科、老年和吞咽困难患者中。它们的益处不仅限于人类使用,还包括兽医应用,可改善不同动物物种的给药方式和适口性。尽管具有这些优点,但目前的咀嚼制剂并未考虑个体化给药和适口性偏好。有鉴于此,三维(3D)打印,特别是半固体挤出技术,已被提议作为一种生产定制咀嚼剂型的新型制造方法。这种先进方法为选择患者特定剂量、辅料和感官特性提供了灵活性,这些对于确保疗效、安全性和治疗依从性至关重要。本综述概述了人类和兽医使用的咀嚼剂型的最新进展,强调了使用它们的动机,并涵盖了制剂考虑因素以及监管方面。